{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:58:15Z","timestamp":1783033095542,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.euroneuro.2005.02.006","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T13:53:39Z","timestamp":1113918819000},"page":"573-585","source":"Crossref","is-referenced-by-count":179,"title":["Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial"],"prefix":"10.1016","volume":"15","author":[{"given":"Roger S.","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Huizar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2005.02.006_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(02)00075-7","article-title":"Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study","volume":"76","author":"Altamura","year":"2003","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"159","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-3223(97)00190-X","article-title":"Multiple fixed doses of \u201cSeroquel\u201d (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group","volume":"42","author":"Arvanitis","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.schres.2003.06.001","article-title":"Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia","volume":"66","author":"Buckley","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib6","unstructured":"CGI: Clinical Global Impressions, 1970. In: Guy W. and Bonato R. (Eds.) Manual for the ECDEU Assessment Battery. National Institute of Mental Health, Chevy Chase, MD, pp. 12-1 to 12-6."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib7","article-title":"Clinical response to quetiapine add-on for treatment of refractory bipolar disorder","author":"Chisholm","year":"2001"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S0033291799001476","article-title":"A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, \u2018Seroquel\u2019) and haloperidol in schizophrenia","volume":"30","author":"Copolov","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib9","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"DelBello","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"issue":"Suppl. 1","key":"10.1016\/j.euroneuro.2005.02.006_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000068018","article-title":"Results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres","volume":"46","author":"Dittmann","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib11","author":"Dunayevich","year":"2001"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004850-200015030-00001","article-title":"A comparison of the effects of quetiapine (\u2018Seroquel\u2019) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group","volume":"15","author":"Emsley","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib14","article-title":"Effects of newer vs. older antidepressants in bipolar depression","author":"Ghaemi","year":"2003"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","article-title":"Guidelines for the biological treatment of bipolar disorders: Part II. Treatment of mania","volume":"4","author":"Grunze","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.euroneuro.2005.02.006_bib18","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1016\/S0924-977X(01)00111-0","article-title":"Quetiapine: efficacy and tolerability in schizophrenia","volume":"11","author":"Kasper","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.yic.0000138822.62874.fd","article-title":"Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia","volume":"19","author":"Kasper","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.155.5.646","article-title":"12-Month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode","volume":"155","author":"Keck","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib23","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib25","first-page":"70","article-title":"Quetiapine in combination with mood stabilizer for the treatment of acute mania associated with bipolar disorder (abstract P140)","volume":"5","author":"Mullen","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hup.549","article-title":"Switching to quetiapine in patients with acute mania who were intolerant to risperidone","volume":"19","author":"Pae","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4088\/JCP.v62n0911","article-title":"Quetiapine alone and added to a mood stabilizer for serious mood disorders","volume":"62","author":"Sajatovic","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib30","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200209000-00003","article-title":"Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status","volume":"17","author":"Shi","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib34","first-page":"265","article-title":"Lithium combined with carbamazepine or haloperidol in the treatment of mania","volume":"31","author":"Small","year":"1995","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archpsyc.1997.01830180067009","article-title":"Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group","volume":"54","author":"Small","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI\u2013BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1034\/j.1399-5618.2002.01204.x","article-title":"Quetiapine in the treatment of rapid cycling bipolar disorder","volume":"4","author":"Vieta","year":"2002","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2005.02.006_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","article-title":"Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group","volume":"30","author":"White","year":"1997","journal-title":"Psychopathology"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.02.006_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v61n0307","article-title":"Clinical predictors of acute response with quetiapine in psychotic mood disorders","volume":"61","author":"Zarate","year":"2000","journal-title":"J. Clin. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:29:27Z","timestamp":1683073767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0924977X05000441"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.02.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}